Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-11

Clinical Trial Update: Olanzapine Dose Comparison for the Prevention of HER-INV: A Network Meta-Analysis

View source ↗

Summary

This clinical trial update describes a planned network meta-analysis comparing different olanzapine dose regimens for preventing chemotherapy-induced nausea and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Olanzapine (Zyprexa) (olanzapine)

Snippet

Sponsor: Shandong Cancer Hospital and Institute | Conditions: Solid Tumours, Olanzapine | Status: RECRUITING